Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 15/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 15/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 9/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 8/20 | 0.38 |
| ▸ | MET | P08581 | 1/20 | 0.38 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.34 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30107942 | 0.88 | ADORA2A (0.47) | ADORA2AADORA1ADORA2BADORA3 | |
| SCHEMBL30108066 | 0.86 | ADORA2A (0.44) | ADORA2AADORA1ADORA2BADORA3MET | |
| SCHEMBL30107952 | 0.85 | ADORA2A (0.41) | ADORA2AADORA1ADORA2BADORA3CSNK1A1 | |
| SCHEMBL30108002 | 0.79 | ADORA2A (0.37) | ADORA2AADORA1 | |
| SCHEMBL30107959 | 0.76 | KDM4E (0.44) | ADORA2AADORA1ADORA2BADORA3CSNK1A1 | |
| SCHEMBL30108062 | 0.74 | MAPT (0.39) | ADORA2AADORA1ADORA2BADORA3MET | |
| SCHEMBL30108049 | 0.72 | TSHR (0.45) | ADORA2AADORA1ADORA2BADORA3 | |
| SCHEMBL30107978 | 0.72 | KDM4E (0.44) | ADORA2AADORA1ADORA2BADORA3CSNK1A1 | |
| SCHEMBL30107979 | 0.71 | CDC7 (0.45) | ADORA2AADORA1ADORA2BADORA3CSNK1A1 | |
| SCHEMBL30108043 | 0.71 | ADORA2A (0.41) | ADORA2AADORA1ADORA2BADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022203399-A1 | ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF | 주식회사 스탠다임 | 2022-09-29 | — | — | WO | disclosed |